Mealey's PI/Product Liability - All Pre-Sept. 14, 2010, Cases In Fosamax Leg Fracture MDL Dismissed As Preempted

Mealey's PI/Product Liability - All Pre-Sept. 14, 2010, Cases In Fosamax Leg Fracture MDL Dismissed As Preempted

TRENTON, N.J. - The New Jersey federal judge overseeing the Fosamax femur fracture multidistrict litigation on March 26 granted summary judgment as a matter of law (JMOL) in several cases after finding that claims of injuries occurring before Sept. 14, 2010, are preempted because the Food and Drug Administration refused to allow the type of warning the plaintiffs claim manufacturer Merck Sharp & Dohme Corp. failed to make (In Re: Fosamax $(Alendronate Sodium$) Products Liability Litigation, MDL Docket No. 2243, No. 3:11-5304, D. N.J.).

Find full version on lexis Advance®
Access this news story on lexis.com®